XML 22 R8.htm IDEA: XBRL DOCUMENT v3.2.0.727
Financial Instruments
6 Months Ended
Jun. 30, 2015
Financial Instruments.  
Financial Instruments

3.Financial Instruments

 

The following tables present information about the Company’s financial assets and liabilities that have been measured at fair value, and indicates the fair value hierarchy of the valuation inputs utilized to determine such fair value. The Company determines the fair value of the preferred stock warrants (Note 6) using Level 3 inputs. Below is a summary of assets and liabilities measured at fair value on a recurring basis (in thousands):

 

 

 

As of June 30, 2015

 

 

 

Quoted Prices
in Active
Markets
(Level 1)

 

Significant
Observable
Inputs
(Level 2)

 

Significant
Unobservable
Inputs
(Level 3)

 

Total

 

 

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

Cash Equivalents

 

17,005 

 

 

 

17,005 

 

 

 

 

 

 

 

 

 

 

 

Total

 

$

17,005 

 

$

 

$

 

$

17,005 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of December 31, 2014

 

 

 

Quoted Prices
in Active
Markets
(Level 1)

 

Significant
Observable
Inputs
(Level 2)

 

Significant
Unobservable
Inputs
(Level 3)

 

Total

 

 

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

Cash Equivalents

 

13,506 

 

 

 

13,506 

 

 

 

 

 

 

 

 

 

 

 

Total

 

$

13,506 

 

$

 

$

 

$

13,506 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities:

 

 

 

 

 

 

 

 

 

Warrant Liability

 

 

 

108 

 

108 

 

 

 

 

 

 

 

 

 

 

 

Total

 

$

 

$

 

$

 

$

108 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As of June 30, 2015 and December 31, 2014, the Company’s cash equivalents consisted principally of money market funds, which approximate their fair value due to their short-term nature. In connection with the completion of the IPO, warrants exercisable for Preferred Stock were automatically converted into warrants exercisable for Common Stock, resulting in the reclassification of the related warrant liability to additional paid-in capital as the warrants to purchase shares of Common Stock are accounted for as equity instruments (Note 6).